Order Article Reprints

Wicky P-H, Poiraud J, Alves M, Patrier J, d’Humières C, Lê M, Kramer L, de Montmollin É, Massias L, Armand-Lefèvre L, et al. Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review. Antibiotics. 2023; 12(6):991. https://doi.org/10.3390/antibiotics12060991

Wicky, Paul-Henri, Joséphine Poiraud, Manuel Alves, Juliette Patrier, Camille d’Humières, Minh Lê, Laura Kramer, Étienne de Montmollin, Laurent Massias, Laurence Armand-Lefèvre, and et al. 2023. "Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review" Antibiotics 12, no. 6: 991. https://doi.org/10.3390/antibiotics12060991

Wicky, P.-H., Poiraud, J., Alves, M., Patrier, J., d’Humières, C., Lê, M., Kramer, L., de Montmollin, É., Massias, L., Armand-Lefèvre, L., & Timsit, J.-F. (2023). Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review. Antibiotics, 12(6), 991. https://doi.org/10.3390/antibiotics12060991